MedTrace Logo

Effect of rTMS of the Cerebellum on Parkinson's Disease

NCT05850598 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-11-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the efficacy of low-frequency rTMS of the cerebellum in Parkinson's disease.

Conditions

  • Parkinson Disease
  • Transcranial Magnetic Stimulation

Interventions

DEVICE

sham rTMS

The coil was held while disconnected from the stimulator, and rTMS noise was presented with computer loudspeakers with recorded sound from a real stimulation (20 minutes for each side of the lateral cerebellum everyday for 2 weeks).

DEVICE

active rTMS

Low-frequency (1 Hz) rTMS at with a stimulation intensity of 95% of the motor threshold will be delivered over the bilateral cerebellum for patients with Parkinson's disease (20 minutes for each side of the lateral cerebellum everyday for 2 weeks).

Sponsors & Collaborators

  • Nanjing University

    collaborator OTHER

  • Jiangsu Province Nanjing Brain Hospital

    lead OTHER

Principal Investigators

  • Yang Pan, M. D. · Jiangsu Province Nanjing Brain Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2025-10-21
Completion
2025-11-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05850598 on ClinicalTrials.gov